After the massive Eaton fire, a seasoned firefighter found relief from smoke‑related symptoms with a controversial antioxidant.
In the days following California’s second‑worst wildfire, Fire Captain David Marquez inhaled his first dose of glutathione outside the Rose Bowl stadium. He reported immediate improvement after hours of chronic cough, headaches, and fatigue.
Glutathione is a naturally‑produced antioxidant that has been marketed to firefighters nationwide as a means to expel cancer‑causing chemicals absorbed in smoke. Despite anecdotal praise from volunteer clinicians and volunteer fire departments, the International Association of Fire Fighters (IAFF) has warned that there is no large‑scale safety data and that recent recalls have highlighted potential contamination.
“We don’t know if it’s effective or a placebo,” said IAFF assistant‑president Sean DeCrane. “The long‑term effects are unknown.”
Naturopathic groups, such as the Integrated Health Action Network, continue to provide glutathione to crews at major fires and claim it reduces headaches and fatigue. However, spokesperson Jen Riegle stresses that their gathered data is purely anecdotal, not clinical‑trial evidence.
Laboratory studies on other antioxidant supplements show mixed results, and experts warn that the debate often distracts from proven measures—like advanced respirators and thorough decontamination—needed to protect firefighters from inhalation hazards.
Regulatory policy also lags: last year the National Forest Service temporarily banned fire‑fighter masks for rugged terrain, only recently allowing them again. The movement to restrict glutathione production was stalled amid opposition from firefighters who argue it benefits their health.
As California’s state Board of Pharmacy proposed stringent controls on glutathione, some firefighters testified in Sacramento that the supplement had improved their well‑being. The IAFF response urges caution until controlled trials confirm efficacy and purity.
Today, younger crews are more committed to health, yet the glutathione debate remains unresolved—highlighting the broader challenge of balancing innovative treatments with solid research in disaster‑management health protocols.
